Dr. Rishi Jindal, MD

Dr. Jindal practices at Outpatient Surgery of Del Mar in San Diego, California.

Dr. Jindal's NPI, 1619293909, was assigned on April 13, 2010. Dr. Jindal graduated from University of Pittsburgh School of Medicine in 2008. Dr. Jindal holds California license A149221.

Dr. Jindal's primary practice is Outpatient Surgery of Del Mar, at 12264 El Camino Real Suite 55, San Diego, CA 92130. The practice phone is (858) 847-0667.

Dr. Jindal's primary practice is Outpatient Surgery of Del Mar in San Diego, California. Dr. Jindal is also affiliated with Sharp Memorial Hospital. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Jindal to 1 more hospital, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jindal practices, 7 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Jindal's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Jindal is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Jindal's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists breast reconstruction, head wound and removal of damaged skin or skin graft among the conditions Dr. Jindal treats.

CMS data shows 157 Medicare services from Dr. Jindal across 6 procedure codes in 2024, for 74 Medicare patients. Medicare paid $27,325 for them.

CMS counts 74 Medicare patients who saw Dr. Jindal in 2024. The largest group is 65 to 74, with 41 patients. 73% of them have high cholesterol, and 54% have arthritis. 24% are also on Medicaid. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Jindal's median patient age at 56, with 74% women.

In 2024, Dr. Jindal wrote 83 Medicare Part D claims for 50 patients. 99% of them were for generic drugs. CMS names the drug for 38 of them, across 1 drug with 11 or more claims each, at $356 in total drug cost. In 2023, CMS named 22 claims across 1 drug.

Dr. Jindal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of mastectomy by Dr. Jindal, more than 84% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Jindal, published from 2010 to 2018. 2018 was the busiest year, with 2. The most frequent topics are Plastic Surgery Procedures, Hindlimb and Surgical Flaps. Dr. Jindal has published most often in Plast Reconstr Surg. Dr. Jindal's most frequent co-authors are Vijay S. Gorantla, MD, PhD, Walter John Joseph, MD and Wei-Ping Andrew Lee, MD.

CMS Open Payments shows 116 general payments to Dr. Jindal from 30 drug and device companies from 2016 to 2025. Grants make up the largest share, 62% of the total. Arthrex, Inc. paid the most, $7,583.

Dr. Jindal graduated from University of Pittsburgh School of Medicine in 2008.

Dr. Jindal is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.